home / stock / lly / lly articles

LLY Articles, Eli Lilly and Company - From 05/25/24

Stock Information
Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com
Menu
LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...
Elon Musk Says Ozempic 'Will Become Very Cheap' After New Comedy Special Paints It As Weight Loss Drug Only Wealthy People Can Afford | Benzinga

Tesla and SpaceX CEO Elon Musk made a bold prediction about the future cost of Novo Nordisk’s (NYSE:NVO) Ozempic, a popular drug being used ...
Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss Meds | Benzinga

Friday, Eli Lilly And Company (NYSE:LLY) announced it has more than doubled its investment in its Lebanon, Indiana, manufa...

Jim Cramer Says This Basic Materials Stock Is 'Too Dicey,' Shares His Take On Arista Networks | Benzinga

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Arista Networks, Inc. (NYSE:ANET) reported an “unbelievable” qu...

Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns | Benzinga

Australia announced on Wednesday that it would ban compounded versions of weight-loss drugs like Novo Nordisk A/S’s (NYSE...
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan | Benzinga

The Structure Therapeutics (NASDAQ:GPCR) stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a...

Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You | Benzinga

On Tuesday, Nestlé SA (OTC:NSRGF) (OTC:NSRGY) unveiled Vital Pursuit, a new line of foods designed to complement GLP-1 weight loss ...

Eli Lilly Secures China Nod For Popular Weight Loss/Diabetes Drug Tirzepatide | Benzinga

On Tuesday, Eli Lilly And Company (NYSE:LLY) announced that Chinese regulators have approved its diabetes drug tirzepatide.  This ap...
Here's How Much $100 Invested In Eli Lilly and Co 5 Years Ago Would Be Worth Today | Benzinga

Eli Lilly and Co (NYSE:LLY) has outperformed the market over the past 5 years by 32.88% on an annualized basis producing an average annual return o...

Should You Invest in the Vanguard Health Care ETF? | Benzinga

Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Vanguard Health Care ETF (ARCA:VHT), a p...

4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly | Benzinga

The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021...
Previous 10 Next 10